Scientists find class of drugs against gram-negative bacteria

02/18/2010 | Yahoo!

Swiss researchers discovered a class of antibiotics that targets Pseudomonas aeruginosa and other forms of drug-resistant, gram-negative bacteria by inhibiting a protein essential for developing the bacteria's outer cell membrane. Swiss biotech firm Polyphor is in discussions with drugmakers as it seeks to license POL7080, its lead drug candidate against Pseudomonas aeruginosa, said Michael Altorfer, the company's chief financial officer.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park